Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pharmacogenetics & Genomics

• Publication date

  2012-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/FPC.0b013e328356fa90PMID 23026812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Research confuses me: what is the difference between case-control and cohort studies in quantitative research?

  2013cited by this paper
• The neurobiology of depression.

  2012cited by this paper
• Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade

  2011cited by this paper
• Neural circuitry and neuroplasticity in mood disorders: Insights for novel therapeutic targets

  2011cited by this paper
• Intravenous injection of neural progenitor cells improves cerebral ischemia-induced learning dysfunction.

  2011cited by this paper
• Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice.

  2011cited by this paper
• Antidepressants and the resilience to early-life stress in inbred mouse strains

  2011cited by this paper
• Reply to: Gamma-Aminobutyric Acidergic Deficits Cause Melancholic Depression: A Reply to Markou and Geyer

  2011cited by this paper
• NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses

  2011cited by this paper
• The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions.

  2011cited by this paper
• Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.

  2011cited by this paper
• Depression and self-reported functional status: impact on mortality following acute myocardial infarction.

  2011cited by this paper
• Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants.

  2011cited by this paper
• A meta-analysis of cytokines in major depression.

  2010cited by this paper
• History of suicide attempts among patients with depression in the GENDEP project.

  2010cited by this paper
• Impact of severity and type of depression on quality of life in cases identified in the community

  2010cited by this paper
• Gene expression patterns in the hippocampus and amygdala of endogenous depression and chronic stress models

  2010cited by this paper
• Health-Related Quality of Life in Depression: A Star*D Report

  2010cited by this paper
• Retraction. Allelic variation in the serotonin transporter promoter modulates cortical excitability.

  2010cited by this paper
• Explained factors of suicide attempts in major depression.

  2010cited by this paper
• Health related quality of life in recurrent depression: a comparison with a general population sample.

  2010cited by this paper
• Type D personality predicts clinical events after myocardial infarction, above and beyond disease severity and depression.

  2010cited by this paper
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

  2010cited by this paper
• Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression

  2009cited by this paper
• Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans

  2009cited by this paper
• Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

  2009cited by this paper
• Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action

  2009cited by this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction.

  2009cited by this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management.

  2009cited by this paper
• 14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria.

  2009cited by this paper
• Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

  2009cited by this paper
• Update on Molecular Psychiatry: new publication guidelines and new ways to stay current

  2009cited by this paper
• CREB regulation of nucleus accumbens excitability mediates social isolation–induced behavioral deficits

  2009cited by this paper
• Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis

  2009cited by this paper
• Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial

  2009cited by this paper
• Corticolimbic Transcriptome Changes are State-Dependent and Region-Specific in a Rodent Model of Depression and of Antidepressant Reversal

  2009cited by this paper
• Does Dual Antidepressant Therapy as Initial Treatment Hasten and Increase Remission from Depression?

  2009cited by this paper
• The molecular neurobiology of depression

  2008cited by this paper
• No association with the 5,10‐methylenetetrahydrofolate reductase gene and major depressive disorder: Results of the depression case control (DeCC) study and a meta‐analysis

  2008cited by this paper
• Episode-Specific Differential Gene Expression of Peripheral Blood Mononuclear Cells in Rapid Cycling Supports Novel Treatment Approaches

  2008cited by this paper
• Serotonin facilitates long‐term depression induction in prefrontal cortex via p38 MAPK/Rab5‐mediated enhancement of AMPA receptor internalization

  2008cited by this paper
• Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression

  2008cited by this paper
• Population-based study of first onset and chronicity in major depressive disorder.

  2008cited by this paper
• Linkage disequilibrium mapping of a chromosome 15q25-26 major depression linkage region and sequencing of NTRK3.

  2008cited by this paper
• The molecular neurobiology of depression.

  2007cited by this paper
• A verification protocol for the probe sequences of Affymetrix genome arrays reveals high probe accuracy for studies in mouse, human and rat

  2007cited by this paper
• Antidepressant-Induced Neurogenesis in the Hippocampus of Adult Nonhuman Primates

  2007cited by this paper
• The functional impact of SLC6 transporter genetic variation.

  2007cited by this paper
• Proteomic analysis of rat cortical neurons after fluoxetine treatment.

  2007cited by this paper
• Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.

  2006cited by this paper
• Medication augmentation after the failure of SSRIs for depression.

  2006cited by this paper
• Gene Expression in the Brain from Fluoxetine‐Injected Mouse Using DNA Microarray

  2006cited by this paper
• Major depressive disorder: remission of associated symptoms.

  2006cited by this paper
• Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment

  2006cited by this paper
• RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis

  2006cited by this paper
• A neurotrophic model for stress-related mood disorders.

  2006cited by this paper
• Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.

  2006cited by this paper
• The role of CREB in depression and antidepressant treatment.

  2006cited by this paper
• Cyclic AMP response element binding protein and brain-derived neurotrophic factor: Molecules that modulate our mood?

  2006cited by this paper
• Loss of brain‐derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice

  2005cited by this paper
• Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells.

  2005cited by this paper
• The many faces of CREB.

  2005cited by this paper
• Model organisms: The ascent of mouse: advances in modelling human depression and anxiety

  2005cited by this paper
• Escitalopram in clinical practice: Results of an open‐label trial in a naturalistic setting

  2005cited by this paper
• Depression: a case of neuronal life and death?

  2004cited by this paper
• Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy.

  2004cited by this paper
• Psychological autopsy studies of suicide: a systematic review

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects

  2003cited by this paper
• Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders

  2003cited by this paper
• The economic burden of depression in the United States: how did it change between 1990 and 2000?

  2003cited by this paper
• Neurobiology of depression.

  2002cited by this paper
• Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines

  2002cited by this paper
• Switching antidepressants for treatment-resistant major depression.

  2001cited by this paper
• Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.

  2001cited by this paper
• Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

  2001cited by this paper
• THE GLOBAL BURDEN OF DISEASE 1990-2020

  2001cited by this paper
• The cellular neurobiology of depression

  2001cited by this paper
• Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.

  2000cited by this paper
• Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus

  2000cited by this paper
• New approaches to the treatment of refractory depression.

  2000cited by this paper
• Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.

  2000cited by this paper
• Mouse Genetics/Genomics: An Effective Approach for Drug Target Discovery and Validation

  2000cited by this paper
• Relation between myocardial infarction, depression, hostility, and death.

  1999cited by this paper
• The global burden of disease, 1990–2020

  1998cited by this paper
• Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone.

  1998cited by this paper
• Global burden of disease.

  1997cited by this paper
• Spontaneous circadian and light-induced expression of junB mRNA in the hamster suprachiasmatic nucleus.

  1996cited by this paper
• Depression and long-term mortality risk in patients with coronary artery disease.

  1996cited by this paper
• Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments

  1995cited by this paper
• Depression and 18-month prognosis after myocardial infarction.

  1995cited by this paper
• A brief self-report depression measure assessing mood state and social impairment.

  1994cited by this paper
• The economic burden of depression in 1990.

  1993cited by this paper
• Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.

  1991cited by this paper
• Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.

  1991cited by this paper
• Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).

  1990cited by this paper
• The economic burden of depression.

  1986cited by this paper

• Galantamine–Escitalopram Combination Therapy in Alzheimer’s Comorbid Depression Model in Mice: Role of BDNF/KYN Pathways, Neuroinflammation, and Oxidative Stress

  2026cites this paper
• Exploring the mechanism of Si-Ni-San against depression by UPLC-Q-TOF-MS/MS integrated with network pharmacology: experimental research

  2023cites this paper
• Transcriptomic Studies of Antidepressant Action in Rodent Models of Depression: A First Meta-Analysis

  2022cites this paper
• Potential Pleiotropic Genes and Shared Biological Pathways in Epilepsy and Depression Based on GWAS Summary Statistics

  2022cites this paper
• Alterations in Astrocytic Regulation of Excitation and Inhibition by Stress Exposure and in Severe Psychopathology

  2022cites this paper
• Candidate Gene Expression Investigation in Children With Attention Deficit Hyperactivity Disorder

  2021cites this paper
• Dose-dependent opposite effects of nortriptyline on affective-like behavior in adolescent rats: Comparison with adult rats.

  2021cites this paper
• Sex-Specific Role for the Long Non-coding RNA LINC00473 in Depression.

  2020cites this paper
• EAAT2 as a Research Target in Bipolar Disorder and Unipolar Depression: A Systematic Review

  2019cites this paper
• Pharmacogenomics in Psychiatric Disorders

  2019cites this paper
• Fetal glucocorticoid receptor (Nr3c1) deficiency alters the landscape of DNA methylation of murine placenta in a sex-dependent manner and is associated to anxiety-like behavior in adulthood

  2019cites this paper
• Regulation at the schizophrenia-associated MIR137 locus and repetitive DNA in the regulation and evolution of brain-related pathway

  2018cites this paper
• Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance

  2017cites this paper
• Stereological Study on the Positive Effect of Running Exercise on the Capillaries in the Hippocampus in a Depression Model

  2017cites this paper
• Transcriptomic profiling of human hippocampal progenitor cells treated with antidepressants and its application in drug repositioning

  2017cites this paper
• A comprehensive regional analysis of genome-wide expression profiles for major depressive disorder.

  2017cites this paper
• Maternal alterations in the proteome of the medial prefrontal cortex in rat.

  2017cites this paper
• The Effect of Atorvastatin on Depression by Forced Swimming Stress model in Gonadectomized Male Mice

  2016cites this paper
• Running exercise protects the capillaries in white matter in a rat model of depression

  2016cites this paper
• Epigenetic differences in monozygotic twins discordant for major depressive disorder

  2016cites this paper
• Mice lacking integrin β3 expression exhibit altered response to chronic stress

  2015cites this paper
• Hippocampal neurogenesis, neurotrophic factors and depression: possible therapeutic targets?

  2015cites this paper
• Regulation of alternative gene transcription in the striatum in response to antidepressant drugs.

  2015cites this paper
• Differential and Converging Molecular Mechanisms of Antidepressants’ Action in the Hippocampal Dentate Gyrus

  2015cites this paper
• Pervasive and opposing effects of Unpredictable Chronic Mild Stress (UCMS) on hippocampal gene expression in BALB/cJ and C57BL/6J mouse strains

  2015cites this paper
• β-Asarone Reverses Chronic Unpredictable Mild Stress-Induced Depression-Like Behavior and Promotes Hippocampal Neurogenesis in Rats

  2014cites this paper
• The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder

  2014influential citation
• Antidepressant treatment response is modulated by genetic and environmental factors and their interactions

  2014cites this paper
• Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder

  2014cites this paper
• Fluoxetine treatment ameliorates depression induced by perinatal arsenic exposure via a neurogenic mechanism.

  2014cites this paper
• Investigating the molecular underpinnings of major depressive disorder and the utility of biomarkers in the inflammatory cytokine pathway as aids for clinical diagnosis and treatment selection

  2014cites this paper
• Aberrant neurogenic and epigenetic processes are associated with depression induced by developmental arsenic exposure

  2014cites this paper
• Differential and converging molecular mechanisms of antidepressants' action in the hippocampal dentate gyrus Running title: Molecular regulation in the dentate gyrus by antidepressants

  2014cites this paper
• Meeting report of the European mouse complex genetics network SYSGENET

  2013cites this paper
• Integrative mouse and human mRNA studies using WGCNA nominates novel candidate genes involved in the pathogenesis of major depressive disorder.

  2013cites this paper
• ATP-binding cassette sub-family F member 1 (ABCF1) is identified as a putative therapeutic target of escitalopram in the inflammatory cytokine pathway

  2013cites this paper